SFA
KRYS icon

Sequoia Financial Advisors’s Krystal Biotech KRYS Stock Holding History

Sequoia Financial Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
923
-70
-7% -$20.9K ﹤0.01% 1575
2026
Q1 		$257K Sell
993
-90
-8% -$23.9K ﹤0.01% 1658
2025
Q4 		$267K Buy
+1,083
New +$228K ﹤0.01% 1627

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sequoia Financial Advisors's KRYS Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Krystal Biotech (KRYS) stake by 7% in Q2 2026, selling an estimated $20.9K and leaving 923 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Sequoia Financial Advisors first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Sequoia Financial Advisors held 923 shares of Krystal Biotech worth $343K as of Q2 2026.
  • Sequoia Financial Advisors sold 70 Krystal Biotech shares in Q2 2026, an estimated $20.9K.
  • Krystal Biotech made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1575 holding.
  • Sequoia Financial Advisors first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.